Vaccines for Young Children Are Coming, but Many Parents Have Tough Questions
The vaccines seem safe for children and are likely to protect against severe illness. But data on efficacy are thin, and most children have already been infected.
The vaccines seem safe for children and are likely to protect against severe illness. But data on efficacy are thin, and most children have already been infected.
The advisers are all but guaranteed to vote yes, despite reservations about the paucity of data, especially regarding the efficacy of the Pfizer-BioNTech vaccine.
As a new version of bird flu spread through North America this spring, scientists began finding the virus in red foxes, bobcats and other mammals.
The cancer eventually will become the third most common type among women, experts say. The mortality rate is highest among Black Americans.
Neither Pfizers nor Modernas pediatric doses have been tested against the subvariants that may soon be dominant in the U.S.
A new survey of the nations abortion providers found increases in every region of the country from 2017 to 2020.
The F.D.A. is also reviewing the treatment, Albrioza, but the agencys scientists have raised questions about its effectiveness.
The virus is not known to linger in the air, agency officials said. But the research is far from definitive.
New estimates based on C.D.C. health surveys point to a stark generational shift in the growth of the transgender population of the United States.
A significantly stronger immune response against Omicron is seen, but it remains unclear how an updated vaccine will fare against future versions of the virus.
The findings indicate that the updated vaccine produced a significantly stronger immune response against Omicron, but it is unclear how it will fare against future versions of the virus.
The spread of the subvariants adds more uncertainty to the trajectory of the pandemic in the United States.
As the number of cases outside Africa approaches 800, governments are scrambling for a limited pool of vaccines and treatments with unclear effectiveness.
Last year, people 65 and older died from Covid at lower rates than in previous waves. But with Omicron and waning immunity, death rates rose again.
Many U.S. hospitals are postponing scans used to diagnose diseases after a Covid lockdown in China hobbled the main U.S. supplier of an imaging chemical.